RT @baryakova: Congrats to @PaulShafer94 for his review paper out in @FrontImmunol! Take a look if you’re interested in the state of the fi…
65 followers
632 followers
While TIL therapy remains an important ACT modality, the manufacture of TIL products is logistically challenging. ACT efforts have thus largely transitioned towards…engineer peripheral blood T cells with receptors that confer desired antigen specificity.
1,896 followers
Terapia celular en cáncer / #AcademiaCTIC - Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects https://t.co/L8dvPZE8fF
105 followers
RT @CARTTherapy: Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects https://t.co/ioqkX25BIF #CART…